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37 INTRODUCTION
38 Patient reported outcome measures (PROMs) are important to fulfill both clinical and research purposes with 
39 regards to assessing knee function in patient with a variety of knee conditions associated with injury, 
40 osteoarthritis or rheumatological disorders. For inclusion into this review, measures of knee function were 
41 required to be pertinent to rheumatology, orthopaedics, and sports medicine specialties. We identified 
42 measures published with scientific analysis and included dimensions that were most important to patients 
43 including pain, quality of life, and activity level.  A 2011 review of 9 tools was published and focused on much of 
44 these issues as they related to rheumatology and orthopaedic surgery.
45
46 Based on the aforementioned criterion and the goals of this review, we used the same 9 measures developed 
47 specifically for patient reported knee function and perceptions: International Knee Documentation Committee 
48 (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and 
49 Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Knee Outcome Survey Activities of Daily 
50 Living Scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster 
51 Universities Osteoarthritis Index (WOMAC), Activity Rating Scale (ARS), and Tegner Activity Score (TAS). This 
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53 January 1, 2010 and March 1, 2020. We also included Patient-Reported Outcomes Measurement Information 
54 System Physical Function (PROMIS-PF) measure based on rising popularity and the amount of research 
55 dedicated for its use in a variety of knee conditions.
56
57 A basic summary of the properties of the different measures is displayed in table 1. Psychometric data 
58 pertaining to the floor and ceiling effects, validity, reliability, responsiveness, and minimum clinically important 
59 difference of each patient reported outcome is displayed in table 2. Floor and ceiling effects were considered to 
60 be absent if no participants scored the bottom or top score, respectively, and acceptable if <15% of the cohort 
61 scored the bottom or top score, respectively. Validity was measured by assessing content, face, and construct 
62 validity. Content validity was present if patients were involved in development. Face validity was present if 
63 expert reviewers made a similar assessment and considered the measured items adequate. Construct validity 
64 was considered adequate if expected correlations were found with existing measures that assess similar 
65 (convergent construct validity) and dissimilar (divergent construct validity) constructs. Internal consistency was 
66 considered adequate if Cronbach’s alpha was at least 0.7 (1), and test–retest (intrarater) reliability was adequate 
67 if the intraclass correlation coefficient was at least 0.8 for groups and 0.9 for individuals. Responsiveness was 
68 determined with a measures ability to detect change over a period of time or intervention. Minimum clinically 
69 important difference is the amount of change of a patient-reported outcome that represents a meaningful 
70 change to the patient.
71
72 Since 2011, there have been numerous studies evaluating the psychometric properties of the above studies. 
73 There has also been ample research assessing the utility and psychometric properties of the PROMIS-PF 
74 function. Extensive work has been performed to add available translations and culturally adapted versions of the 
75 above measures. Our review summarizes the available information about how these measures perform for 
76 different patient populations in different settings.
77 INTERNATIONAL KNEE DOCUMENTATION COMMITTEE (IKDC) SUBJECTIVE KNEE EVALUATION FORM
78 Description
79 Purpose. To detect improvement or deterioration in symptoms, function, and sports activities due to knee 
80 impairment caused by a variety of knee conditions including ligament injuries, meniscal injuries, articular 
81 cartilage lesions, and patellofemoral pain (2).
82 Version. The IKDC was formed in 1987 to develop a standardized international documentation system for knee 
83 conditions. The IKDC Standard Knee Evaluation Form, which was designed for knee ligament injuries, was 
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85 developed as a revision of the Standard Knee Evaluation Form in 1997. It has undergone subsequent minor 
86 revisions since its publication in 2001. 
87 Content. Three domains: 1) symptoms, including pain, stiffness, swelling, locking/catching, and giving way; 2) 
88 sports and daily activities; and 3) current knee function and knee function prior to knee injury (not included in 
89 the total score) (2).
90 Number of items. 18 (7 items for symptoms, 1 item for sport participation, 9 items for daily activities, and 1 item 
91 for current knee function).
92 Response options/scale. Response options vary for each item. Item 6 dichotomizes response into yes/no; items 
93 1, 4, 5, 7, 8, and 9 use 5-point Likert scales; and items 2, 3, and 10 use 11-point numerical rating scales. 
94 Recall period for items. Not specified for items 1, 3, 5, 7, 8, and 9; 4 weeks for items 2, 4, and 6. Function prior 
95 to knee injury for item 10a and current function for 10b.
96 Cost to use. Free to use. Cost of administration and information storage not assessed and varies for each 
97 practice.
98 How to obtain. https://www.sportsmed.org/aossmimis/Staging/Research/IKDC_Forms.aspx
99
100 Practical Application
101 Method of administration. Patient-completed questionnaire. The form has not been validated for 
102 administration by interview, either in person or via telephone.
103 Scoring. The response to each item is scored using an ordinal method (i.e., 0 for responses that represent the 
104 highest level of symptoms or lowest level of function). The most recent version has assigned scores for each 
105 possible response printed on the questionnaire. Scores for each item are summed to give a total score 
106 (excluding item 10a). The total score is calculated as (sum of items)/(maximum possible score)  100, to give a 
107 total score of 100. An online scoring sheet is available (www.sportsmed.org/tabs/ research/ikdc.aspx) that 
108 provides a patient’s raw score and percentile score (relative to age- and sex-based norms). The item regarding 
109 knee function prior to knee injury is not included in the total score. The revised scoring method states that, in 
110 cases where patients have up to 2 missing values (i.e., responses have been provided for at least 16 items), the 
111 total score is calculated as (sum of completed items)/ (maximum possible sum of completed items) 100.          
112 Score interpretation. Possible score range 0–100, where 100  no limitation with daily or sporting activities and 
113 the absence of symptoms. Normative data are available from the general US population, stratified for age, sex, 
114 and current/prior knee problems (5).
115 Respondent burden. 10 minutes to complete (6). It uses simple language that is suitable for patients.
116 Administrative burden. Approximately 5 minutes to score. Training is not necessary. Manual scoring can be 
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118 Translations/adaptations. Available in English, Arabic, Brazilian Portuguese, traditional Chinese (Taiwan, Hong 
119 Kong), simplified Chinese (China, Singapore), Czech, Dutch, French, German, Greek, Italian, Japanese, Korean, 
120 Norwegian, Polish, Spanish, Swedish, Thai, Turkish. Cross-cultural adaptations have been conducted for the 
121 Arabic (7), Brazilian (8), Chinese (9-11), Danish (12), Dutch (13), German (14), Greek (15), Italian (6), Korean (16), 
122 Romanian (17), Thai (18), and Turkish (19) translations.
123 Psychometric Information
124 Method of development. The initial set of items was developed by the IKDC, considering questions from the 
125 Standard Knee Evaluation Form, the MODEMS Lower Limb Instrument, and the Activities of Daily Living and 
126 Sports Activity Scales of the Knee Outcome Survey. Pilot testing of the initial version (n 144) resulted in revision 
127 or deletion of existing items and the addition of new items. Testing of the second version (n 222) resulted in 
128 further revisions and deletions (based on missing data), producing a final version. Item-response theory was 
129 used to create the scoring system. Patients were not involved in development; rather, items were selected by 
130 the IKDC, a committee of international orthopedic surgeons (2). Following development, validation and 
131 implementation of the IKDC, a pediatric form was developed, the Pedi-IKDC, which has been tested for 
132 psychometric properties and normative data as well as is electronic use (20-22).
133 Floor and ceiling effects. Studies consistently report no floor or ceiling effects (i.e., no participants scored lowest 
134 or highest score) (2, 6, 8, 13, 15, 23, 24).
135 Reliability. Internal consistency is adequate for patients with knee injuries and mixed knee pathologies (Table 1). 
136 Test–retest reliability is adequate for groups of patients with knee injuries and mixed pathologies and individuals 
137 with knee injuries. It also has been shown to be adequate in pediatric populations (20). The test–retest reliability 
138 is slightly below adequate for individuals who fall into a broader category of knee pathologies. However, studies 
139 have shown superior reliability over other measurement forms. The Chinese IKDC has better reliability than the 
140 Chineses KOOS (25). The Dutch IKDC had better reliability than the WOMAC and KOOS for meniscal injury (26). 
141 Validity. Face and content validity. The domains covered by the IKDC appear to represent elements that are 
142 likely to be important to patients. However, the lack of patient contribution to the selection and revision of 
143 items in the IKDC means that content validity cannot necessarily be assumed.
144 Construct validity. There are consistent reports of high convergent and divergent construct validity, with the 
145 IKDC more strongly correlated with the Short Form 36 (SF-36) physical subscales and component summary than 
146 with the mental subscales and component summary (2, 8, 11, 13, 23, 24, 27,). Construct validity is acceptable in 
147 the pediatric form (20) and improved over the KOOS-Child form (28). Studies have shown the IKDC score to be 
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149 Western Ontario and McMaster Universities Osteoarthritis Index, Lysholm score, and SF-36 physical component, 
150 physical function, and bodily pain subscales (8, 13, 29).
151 Responsiveness. The IKDC has been shown to be adequately responsive (24). In a study comparing 
152 responsiveness of the IKDC versus KOOS for ACL injuries, the IKDC was found to be adequately responsive and 
153 the KOOS was not (30). The same finding was found in a Chinese study comparing IKDC versus KOOS (25). 
154 Further testing has specifically shown its adequate responsiveness for meniscal injury (31). The Pedi- IKDC has 
155 also been shown to have acceptable responsiveness (20). When directly compared to the KOOS-Child, it has 
156 superior responsiveness (28).  
157 Minimally Important Differences. The minimal detectable change has been reported to be between 8.8 and 
158 15.6, and the standard error of the measure between 3.2 and 5.6. Few studies have shown the minimal 
159 important changes. One study shows the minimal important change to be 10.9 for meniscal injuries (31). 
160 Another showed it to be 9.8 in the Chinese population (25) and another showed 12.0 for pediatric populations 
161 (12). The minimum clinically important difference has been reported to be 6.3 at 6 months and 16.7 at 12 
162 months following cartilage repair (32), and 11.5–20.5 (range 6–28 months) in those who have undergone various 
163 surgical procedures for mixed (various) knee pathologies (33). The patient-acceptable symptom state has not 
164 been determined.
165
166 Critical Appraisal of Overall Value to the Rheumatology Community
167 Strengths. At face value, the domains covered by the IKDC appear to represent elements that are likely to be 
168 important to patients. It shows adequate internal consistency and has no floor or ceiling effects across mixed 
169 groups of patients with knee conditions. The IKDC has been shown to be responsive to change following surgical 
170 interventions, highlighting its usefulness in this patient population. It has particularly been shown to be a 
171 stronger measure for ACL injuries and meniscal injuries. It has also been shown to be a strong measure in the 
172 pediatric population.
173 Caveats and cautions. Despite demonstrating face validity, the lack of patient contribution to item selection 
174 indicates that content validity cannot necessarily be assumed and has not been thoroughly investigated. The 
175 relatively long recall period associated with 3 of the items may be a problem for some patients. The use of 1 
176 aggregate score to represent symptoms, activities, and function may mask deficits in 1 domain. Psychometric 
177 testing is lacking for patients with knee osteoarthritis as an isolated group, as well as responsiveness following 
178 nonsurgical management, highlighting areas for future studies. 
179 Clinical usability. The IKDC involves minimal administrative and respondent burden, and can be easily scored in 
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181 mind that the normative data provided are from a particular population, and may not be representative of their 
182 individual patient’s population. 
183 Research usability. Psychometric evaluation supports the use of the IKDC in research for a variety of knee 
184 conditions. As some versions of the IKDC published online contain subtle differences in the wording of 
185 instructions and items, researchers should ensure that they utilize the version published as a component of the 
186 2000 IKDC Knee Forms to ensure that findings of psychometric properties still apply, and that comparisons can 
187 be made with previous studies. Administrative and respondent burden would not limit research use, although 
188 researchers should be diligent in checking for missing data.
189 KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE (KOOS)
190 Description
191 Purpose. To measure the opinions of young, middle-aged, and elderly patients’ with posttraumatic osteoarthritis 
192 (OA), and other injuries leading to OA, in regards to their knee and associated problems over short and long-
193 term follow up (34).  Examples of conditions includes knee ligament injury (ACL, posterior cruciate ligament 
194 [PCL], medial collateral ligament [MCL]), meniscal tears, knee cartilage lesions, knee OA, and osteochondritis 
195 dissecans. Interventions: ligament reconstruction (ACL, PCL, MCL), meniscectomy, microfracture, osteochondral 
196 autografts, tibial osteotomy, total knee replacement (TKR), exercise (land based, aquatic), intraarticular sodium 
197 hyaluronate injection, pharmacologic therapy, and glucosamine supplementation.
198 Content. Five domains: 1) pain frequency and severity during functional activities; 2) symptoms such as the 
199 severity of knee stiffness and the presence of swelling, grinding or clicking, catching, and range of motion 
200 restriction; 3) difficulty experienced during activities of daily living (ADL); 4) difficulty experienced with sport and 
201 recreational activities; and 5) knee-related quality of life (QOL) (34). The original KOOS remains unchanged, 
202 although there have been other subscales developed including the Koos-12 short form, the KOOS- Joint 
203 Replacement form, and the KOOS-Child form
204 Number of items. 42 items across 5 subscales. 
205 Response options/scale. All items are rated on a 5-point Likert scale (0–4), specific to each item.
206 Recall period for items. Previous week for pain, symptoms, ADL, and sport/recreation subscales. Not defined for 
207 QOL subscale.
208 Cost To Use. Free of Charge. Cost of distribution, collection and data storage not assessed.
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211 Method of administration. Patient-completed, in-person questionnaire. Can be administered on paper, tablet or 
212 computer.
213 Scoring. Scoring sheets (manual and computer spreadsheets) are provided on the web site. Each item is scored 
214 from 0–4. The 5 dimensions are scored separately as the sum of all corresponding items.. Scores are then 
215 transformed to a 0–100 scale (percentage of total possible score achieved)(34). If a mark is placed outside a box, 
216 the closest box is chosen. If 2 boxes are marked, that which indicates more severe problems is chosen. One or 2 
217 missing values within a subscale are substituted with the average value for that subscale. If 2 items are missing, 
218 the response is considered invalid and a subscale score is not calculated.
219 Score interpretation. 0 is equivalent to the most severe knee problems and 100 representative of no knee 
220 problems..Population-based normative data are available, stratified by age and sex (35).
221 Respondent time to complete. The KOOS takes 10 minutes to complete (34). It uses simple language and similar 
222 1-word responses for each item. 
223 Administrative burden. Approximately 5 minutes to score, if using the scoring spreadsheet. Can be 
224 automatically calculated with any time of data management software
225    Translations/adaptations.  
226 Arabic (Egypt), Arabic (Saudi Arabia), Austria-German, Bengali (India), Czech, Chinese (Hong Kong), Chinese 
227 (Singapore), Croatian, Danish, Dutch, Estonian, English, Finnish, Filipino (Philippines), French, German, Greek, 
228 Hindi (India), Icelandic, Italian Japanese, Kannada (India), Korean, Latvian, Lithuanian, Malayalam (India), Malay, 
229 Marathi (India), Norwegian, Persian, Portuguese, Portuguese (Brazil), Polish, Romanian, Russian, Singapore, 
230 English, Slovakian, Slovenian, Spanish, Spanish (US), Spanish (Peru), Swedish, Tamil (India), Telugu (India), Thai, 
231 Turkish, Ukrainian, Urdu (India), Vietnamese, Welsh, Zulu. Validation of the cross-cultural adaptations have been 
232 conducted and found adequate in the following languages (36,37), Mainland Chinese (38, 39), Singapore Chinese 
233 (40), Greek (41), Icelandic (42), Spanish (43,44),  Dutch (45), French (46), Saudi Arabic (47), Hong Kong (48), 




238 Floor and ceiling effects. Studies consistently report no or acceptable floor or ceiling effects in knee injury 
239 cohorts (36, 50, 54) and in patients with mild or moderate knee OA (37, 40, 46, 51).  In those with severe OA 
240 awaiting TKR (37, 40, 45, 46, 51), there are consistent reports of floor effects for the sport/recreation subscale 
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242 (16%), and QOL (17%) subscales up to 12 months following TKR (37). Comparatively, it has been shown to have 
243 lower ceiling effects in all categories except for pain against the Knee Society Function score (55). Studies have 
244 shown that the original KOOS was not well understood by children and subsequently the KOOS-Child was 
245 formed (56). The KOOS-Child was found to have no floor or ceiling effects (57).
246 Reliability. For patients with knee injuries, the pain, ADL, and sport/recreation subscales have adequate internal 
247 consistency in all reports, while the symptom and QOL subscales have had reports of lower as well as adequate 
248 internal consistency (Table 1). In patients with knee OA, the ADL, sport/recreation, and QOL subscales have 
249 adequate internal consistency, while the pain and symptoms subscales have reports of lower as well as 
250 adequate internal consistency. Test–retest reliability is adequate for group evaluation in all reports on the pain, 
251 symptoms, and QOL subscales for patients with knee injuries, while there are reports of lower and adequate 
252 reliability, respectively, for the ADL and sport/recreation subscales. Recent meta-analysis has shown adequate 
253 test–retest reliability for age and condition relevant subscales (58). Across the 5 subscales, the minimal 
254 detectable change ranges from 6–12 for knee injuries and from 13.4–21.1 for knee OA. For the five KOOS 
255 subscales, the pooled smallest detectable change (SDC) for individuals ranged from 15.7 (ADL) to 25.1 (Sport/ 
256 Rec). The SDC was greater for older adults and those with knee OA than for younger and ACL cohorts (58). The 
257 standard error of the measure is reported to be lower for knee injuries than for OA.
258
259 Validity. Face and content validity. As well as exhibiting face validity, the direct involvement of patients with 
260 knee conditions in the development of the KOOS facilitates content validity (34, 37).
261 Construct validity. Multiple studies report that the KOOS demonstrates convergent and divergent construct 
262 validity, with the KOOS more strongly correlated with subscales of the Short Form 36 (SF-36) that measure 
263 similar constructs (e.g., ADL with physical function, sport/ recreation with physical function, pain with bodily 
264 pain), and less strongly with SF-36 subscales that measure mental health (34, 36, 37, 40, 45, 50, 51, 54, 58, 59). 
265 Rasch analysis conducted using patient data 20 weeks post–ACL reconstruction showed that only the 
266 sport/recreation and QOL subscales exhibited unidimensionality, not the 3 subscales that were based on the 
267 WOMAC (60). A more recent study reported that the KOOS subscales had acceptable dimensionality (59). 
268 Further meta-analysis more recently found the hypothesis of superior convergent and divergent construct 
269 validity were supported when all data were pooled, and when split by age group and knee condition for pain, 
270 symptoms, ADL, sports/recreation and QoL(58). They found that further testing was necessary for the short form 
271 as well as needed structural validity in all categories (58).
272 Responsiveness. The KOOS appears to be responsive to change in patients with a variety of conditions that have 
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274 meniscectomy 3 months previously, large effect sizes are seen on all but the ADL subscale. Large effect sizes are 
275 seen in all subscales 6 months after ACL reconstruction. Three years following autologous chondrocyte 
276 implantation or microfracture, large effect sizes are seen for the pain, sport/recreation, and QOL subscales, and 
277 moderate effects on the symptoms and ADL subscales. In those with knee OA who have undergone physical 
278 therapy treatment, large effect sizes are seen at 4 weeks on the pain, symptoms, and ADL subscales, while the 
279 sport/recreation and QOL subscales show moderate effects. Larger effect sizes are found following TKR than 
280 with non-operative treatment (58). Large effect sizes are consistently reported on all subscales 3–12 months 
281 after TKR, but without increasing effect sizes over these periods (58). Large effect sizes have been shown to be a 
282 strength of the KOOS as opposed to other parameters (61). 
283 Minimally important differences. The minimum clinically important difference (MCID) of the KOOS short form 
284 and KOOS QoL has been reported in one study (62). MCID and moderate improvement estimates for KOOS-QOL 
285 were 8.0 and 15.6, respectively (62).
286 Critical Appraisal of Overall Value to the Rheumatology Community
287 Strengths. The KOOS has undergone a substantial amount of psychometric testing. Over the last decade, the 
288 creation of subscales paired with psychometric testing has expanded as well as cultural adaptation testing. 
289 Establishment of the KOOS as a reliable and valid measure across multiple languages highlights its usefulness as 
290 a patient-reported measure of knee function for people with knee OA and various combinations of sports and 
291 trauma related injuries. This has been expanded to include a child form of the test. The use of individual scores 
292 for each subscale, rather than an aggregate score, enhances clinical interpretation and in research acknowledges 
293 the impact of different interventions on different dimensions (e.g., exercise therapy is likely to have more 
294 impact on ADL and sport/recreation, while pharmacology may impact more on pain and symptoms) and ensures 
295 content validity in groups of different ages and functional activity levels (e.g., the sport/ recreation subscale is 
296 more important in patients with a high physical activity level, while the ADL subscale is more important in 
297 subjects with a lower physical activity level).
298 Caveats and cautions. The KOOS has not been validated for interview administration, meaning that it may not 
299 be appropriate for patients who are unable to read or write, or where telephone follow-up is necessary. When 
300 administering the KOOS in older or less physically active individuals, higher level components of the ADL and 
301 sport/recreation subscales may not be applicable, and could result in missing data. It may be appropriate to 
302 leave out the sport/ recreation subscale in those with more advanced disease or disability; however, doing so 
303 omits the ability to measure improvements seen in these more demanding functions following treatment (37). 
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305 Clinical usability. The KOOS is freely available online. Administration and scoring burden are minimal when 
306 online score sheets are utilized. Clinicians should bear in mind that the sport/recreation subscale may not be 
307 applicable for less physically active patients, and may not have adequate test–retest reliability in individuals with 
308 knee injuries.
309 Research usability. The KOOS fulfills desired criteria for research outcomes, demonstrating adequate reliability 
310 for use in groups and validity when used in those with knee injuries and knee OA. The inclusion of the 3 WOMAC 
311 subscales facilitates comparison of findings with studies that have utilized the WOMAC as a primary measure. 
312 The minimal amount of MCID evidence continues to weaken research usability. 
313 KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE PHYSICAL FUNCTION SHORT FORM (KOOS-PS)
314 Description
315 Purpose. Patients’ opinions about the difficulties they experience with physical activity due to their knee 
316 problems.
317 Content. Measure of physical function derived from the activities of daily living and sport/recreation subscales 
318 of the KOOS (63). Patients rate the degree of difficulty they have experienced over the previous week due to 
319 their knee pain, with respect to: 1) rising from bed, 2) putting on socks/stockings, 3) rising from sitting, 4) 
320 bending to the floor, 5) twisting/pivoting on injured knee, 6) kneeling, and 7) squatting.
321 Number of items. 7 items.
322 Response options/scale. All items are scored on a 5-point Likert scale (none, mild, moderate, severe, extreme) 
323 scored from 0–4.
324 Recall period for items. Previous week.
325 Cost to use. Free to use. Cost of administration and data storage is unique to each practice.
326 How to obtain. The KOOS-PS and associated documentation are freely available at www.koos.nu.
327
328 Practical Application
329 Method of administration. Patient-completed questionnaire. Can be completed in paper form or electronic 
330 form.
331 Scoring. Each question is scored from 0–4. The raw score is the sum of the 7 items. The interval score from 0–
332 100 is obtained using a conversion chart (63).  No instructions on how to handle missing values.
333 Score interpretation. Possible raw score range: 0–28. Scores are then transformed to a score from 0–100, where 
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335 Normative values. Not available.
336 Respondent burden. Based on findings for the KOOS, no more than 2 minutes to complete. Uses simple 
337 language and the same 1-word responses for each of the 7 items. As the items relate to everyday tasks, it is not 
338 considered that they would have an emotional impact on the individual.
339 Administrative burden. Less than 5 minutes to score, using the conversion table provided (63). Training is not 
340 necessary, as the questionnaire and scoring instructions are self-explanatory.
341 Translations/adaptations. Available in Arabic, Chinese, Danish, Dutch, English, French, German, Hindi, Italian, 
342 Korean, Norwegian, Polish, Portuguese, Russian, Spanish, Swedish, and Turkish. Can easily be compiled by 
343 extracting the 7 items needed from the full KOOS forms in all languages in which the KOOS is available. Cross-
344 cultural adaptations have been conducted for the French (64), Portuguese (65) and Turkish (66) translations.
345 Psychometric Information
346 Method of development. Rasch analysis was conducted on KOOS and Western Ontario and McMaster 
347 Universities Osteoarthritis Index (WOMAC) data from individuals with knee OA from Sweden, Canada, France, 
348 Estonia, and The Netherlands. Patient data from 13 data sets were used (age 26–95 years, male:female ratio 
349 1:1.4). This included community and clinical samples, such as those who had undergone previous meniscectomy, 
350 tibial osteotomy, or anterior cruciate ligament repair, as well as those scheduled to undergo TKR (63).
351 Acceptability. Rates of missing data have not been reported. Findings of 1 study indicate no floor or ceiling 
352 effects when used in patients with knee OA (i.e., no patients had lowest or highest score, respectively) (64).
353 Reliability. The KOOS-PS has adequate internal consistency and test–retest reliability for groups of patients with 
354 knee OA; however, its reliability is lower than adequate for use in individuals with knee OA (Table 1). The 
355 minimal detectable change and standard error of the measure have not been reported.
356 Validity. Face and content validity. As items are taken directly from the KOOS, which has face and content 
357 validity, this can also be assumed for the KOOS-PS although no studies have evaluated content validity solely for 
358 KOOS-PS (58).
359 Construct validity. The KOOS-PS shows evidence of convergent and divergent construct validity. Higher 
360 correlations have been shown with the Short Form 36 (SF-36) physical function, role physical, and bodily pain 
361 subscales; WOMAC function subscale (excluding KOOS-PS items); and Osteoarthritis Knee and Hip Quality of Life 
362 questionnaire (OAKHQOL) physical activity domain (64, 65, 67). Conversely, lower correlations have been 
363 reported with KOOS pain, symptoms, and quality of life subscales; SF-36 mental health subscales; mental health 
364 questionnaires (e.g., Profile of Mood States, Hospital Anxiety and Depression Scale); and OAKHQOL social 
365 support (64, 65, 67). One study found that, in patients with knee OA, KOOS-PS had a unidimensional structure 
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367 Responsiveness. In patients with knee OA, the KOOS-PS shows moderate to large effect sizes following 4 weeks 
368 of physical therapy, and moderate effects 4 weeks after intraarticular hyaluronic acid injection (Table 2). The 
369 KOOS-PS is also able to discriminate groups of patients based on use of walking aids (65). When compared 
370 directly to the WOMAC physical function subscale, the WOMAC physical function subscale was better able to 
371 detect changes over time in physical function categories (69). One study found the minimum clinically important 
372 difference (MCID) for patients undergoing non-operative treatment for OA to be 12 (70). For KOOS-PS, MCID 
373 and moderate improvements were 2.2 and 15.0.
374 Critical Appraisal of Overall Value to the Rheumatology Community
375 Strengths. The KOOS-PS is one of the few knee-related patient-reported outcomes that utilized Rasch analysis in 
376 its development. Its inclusion of only 7 items facilitates use with short measures of other dimensions, such as 
377 pain visual analog scales, and makes it ideal for those for which long questionnaires may be onerous (e.g., older 
378 populations).
379 Caveats and cautions. The KOOS-PS was intended for use in those with knee OA, and limited evaluation for 
380 other conditions is available. Also, utilizing the Rasch analysis, data suggests that a 12 item short form for 
381 physical function may lead to a more optimal measurement (68). 
382 Clinical usability. The minimal administration and scoring burden associated with the KOOS-PS make it ideal for 
383 clinical use, particularly considering that the included items are frequently asked in the standard clinical 
384 examination. However, clinicians should bear in mind that the reliability has been shown to be less than 
385 adequate for individuals.
386 Research usability. Psychometric testing shows the KOOS-PS to be valid and reliable for use in groups with knee 
387 OA, making it an ideal tool for measuring knee related function in research.
388 KNEE OUTCOME SURVEY ACTIVITIES OF DAILY LIVING SCALE (KOS-ADL)
389 Description
390 Purpose. To determine symptoms and functional limitation in usual daily activities caused by various knee 
391 pathologies (71).
392 Intended populations/conditions. Patients undergoing physical therapy for various knee pathologies, such as 
393 ligament/meniscal injury, osteoarthritis (OA), and patellofemoral pain (71-73). It is applicable for patients 
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395 Version. Although originally described as a single index with 17 items (71), shorter versions have been widely 
396 used. A version using Likert-type scales is also available (76).
397 Content or domains. Single index with 2 sections pertaining to symptoms (pain, crepitus, stiffness, swelling, 
398 instability/ slipping, buckling, and weakness) and functional limitations (difficulty walking on level surfaces, use 
399 of walking aids, limping, going up and down stairs, standing, kneeling, squatting, sitting, and rising from a sitting 
400 position) (71,76). A separate scale has been developed to assess sporting activities (71).
401 Number of items. The original version comprised 17 items (7 for symptoms, 10 for function), but a 14-item 
402 version (6 for symptoms, 8 for function) is also used (71,76).
403 Response options/scale. Patients rate items using descriptive responses, which are translated to a numerical 
404 ordinal scale for scoring. Responses for each item are scored from 0–5, with the exception of item 9 (0–3) and 
405 item 10 (0–2) in the 17-item questionnaire.
406 Recall period for items. 1–2 days.
407 Cost to use. Free
408 How to obtain. Presented in full as an appendix in the original publication (71).
409
410 Practical Application
411 Method of administration. Patient-completed questionnaire. It has not been validated for interview 
412 administration (in person or via telephone).
413 Scoring. The total score is calculated as the sum of scores from the responses to each item, and then 
414 transformed to a percentage score by dividing by the maximum total possible score and multiplying by 100 
415 (71,76).
416 Missing values. While there are no instructions provided as to handling missing data, the original publication 
417 only analyzed questionnaires with no missing data (71).
418 Score interpretation. Possible transformed score range 0–100, where 100 means no knee-related symptoms or 
419 functional limitations.
420 Normative values. Not available.
421 Respondent time to complete. It takes approximately 5 minutes to complete the KOS-ADLS questionnaire (71). 
422 No training or assistance is required as the KOS-ADLS is self-explanatory.
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424 Translations/adaptations. The KOS-ADLS instrument has been validated after translation to Arabic (77,78), 
425 Chinese (79), French (80) German (81), Portuguese (82), Polish (83), Turkish (84), and Greek (85).
426
427 Psychometric Information
428 Floor and ceiling effects. No floor effects have been detected (74,75). Acceptable ceiling effects have been 
429 reported in people with a variety of knee pathologies undergoing physical therapy and orthopedic surgeon 
430 evaluation (71,75). However, high ceiling effects have been reported 6 months after TKR (74).
431 Reliability. In patients with mixed knee pathologies, the KOS-ADLS has demonstrated adequate internal 
432 consistency across multiple languages, as well as adequate test–retest reliability for use in groups and 
433 individuals (Table 1). There has been shown to be high test-retest reliability in patients with patellofemoral pain 
434 syndrome (PFPS) (86). Reliability decreases as the time increases between baseline and follow up measurements 
435 in patients undergoing physical therapy for knee OA (87).
436 Validity. Face and content validity. During development, the KOS-ADLS was examined by orthopedic surgeons 
437 and physical therapists, who thought that it adequately covered the range of functions/painful activities 
438 performed in daily life, ensuring face validity (71). However, since item selection did not involve patient input, 
439 this instrument may lack content validity if the instruments from which items were drawn were not themselves 
440 derived from patient input (71).
441 Construct validity. The KOS-ADLS shows good correlation with other knee-specific scales, such as the Lysholm 
442 Knee Scoring Scale (71), WOMAC subscales (74), and global assessment of function (71). Higher correlations with 
443 the physical than mental component score of the Short Form 12 indicates convergent and divergent construct 
444 validity (74).
445 Responsiveness. The KOS-ADLS demonstrates an ability to detect change in patients with a variety of knee 
446 disorders (Table 2). Among patients undergoing physical therapy for various knee pathologies, small effect sizes 
447 were reported at 1 week, and large effect sizes were reported at 4 and 8 weeks (71). Moderate effect sizes were 
448 reported among patients with PFPS (73). Large effect sizes have been reported following TKR (74). The 
449 responsiveness has been shown to decrease over time in patients undergoing physical therapy for knee OA (87). 
450 The patient acceptable symptom state has not been reported.
451 Minimally important differences. Among patients with PFPS, the minimum clinically important difference has 
452 been determined to be 7.1 (73) and a minimal detectable change of 8.3% (86). In patients undergoing physical 
453 therapy for knee OA, there is an increase in the minimum clinically important difference from 2.2 at 2 months to 
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455 Generalizability. The KOS-ADLS has been used in a variety of knee pathologies. It is likely generalizable to many 
456 knee conditions and many different populations due to the consistent reliability, validity, and responsiveness 
457 that is found in the literature.
458 Use in clinical trials. None reported.
459 Critical Appraisal of Overall Value to the Rheumatology Community
460 Strengths. The KOS-ADLS is a reliable and valid instrument that is responsive to change in patients with a variety 
461 of knee conditions who are undergoing physical therapy or orthopedic procedures.
462 Caveats and cautions. The lack of direct patient input into item selection means that content validity cannot be 
463 assumed. The KOS-ADLS uses more descriptive responses to each item as compared to other patient-reported 
464 outcomes, which may be confusing or overwhelming for some patients, particularly those with reading 
465 difficulties. By design, the KOS-ADLS does not include items pertaining to athletic activities, such as running and 
466 jumping.
467 Clinical usability. The KOS-ADLS is sufficiently reliable to allow use in individuals with a variety of knee disorders.
468 Research usability. The KOS-ADLS is reliable, valid, and appropriate for measuring change following nonsurgical 
469 and surgical interventions in a variety of knee conditions. However, researchers should be aware that if subjects 
470 being evaluated are highly physically active, this instrument is not necessarily valid. Researchers should also be 
471 consistent with which version of the scale they are utilizing.
472 LYSHOLM KNEE SCORING SCALE (LKS) 
473 Description
474 Purpose. To evaluate outcomes of knee ligament surgery, particularly symptoms of instability (88).
475 Intended populations/conditions. Patients with knee ligament injury and anteromedial, anterolateral, combined 
476 anteromedial/anterolateral, posterolateral rotatory, or straight posterior instability (88).
477 Version. First published in 1982 (88). The revised version (1985) added an item regarding knee locking, removed 
478 items regarding pain on giving way, swelling with giving way, and the objective measure of thigh atrophy, and 
479 also removed the reference to walking, running, and jumping above the sections regarding instability, pain, and 
480 swelling (89).
481 Content. The original scale included 8 items: 1) limp; 2) support; 3) stair climbing; 4) squatting; 5) walking, 
482 running, and jumping; and 6) thigh atrophy (88). The revised scale also includes 8 items: 1) limp, 2) support, 3) 
483 locking, 4) instability, 5) pain, 6) swelling, 7) stair climbing, and 8) squatting (89).
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485 Response options/scale. Individual items are scored differently, using individual scoring scales. The revised scale 
486 modified the original scoring slightly: 1) limp (0, 3, 5), 2) support (0, 2, 5), 3) locking (0, 2, 6, 10, 15), 4) instability 
487 (0, 5, 10, 15, 20, 25), 5) pain (0, 5, 10, 15, 20, 25), 6) swelling (0, 2, 6, 10), 7) stair climbing (0, 2, 6, 10), and 8) 
488 squatting (0, 2, 4, 5) (89).
489 Recall period for items. Not specified.
490 Cost of use. The revised version is freely available in the publication (89).




495 Method of administration. Original and revised scales were intended for in-person clinician administration 
496 (administered by the orthopedic surgeon with the patient’s collaboration) (88,89), although subsequent studies 
497 have documented using the scale as a patient-completed questionnaire ( 90). While significantly lower scores 
498 have been found for questionnaires versus interview administration, suggesting interview bias (91), 1 study 
499 reported a high level of agreement between patients and physiotherapists using a modified version of the 
500 Lysholm scale (item for swelling removed) in patients with knee chondral damage (92). Most recently, several 
501 studies have shown that telephone interviews (as opposed to face-to-face) and electronically delivered 
502 questionnaires are indeed reliable modes of administration, with the perceived advantage of fostering multi-
503 center collaborations and potential for more accurate comparisons of outcomes between patient groups 
504 (93,94).
505 Scoring. Each possible response to each of the 8 items has been assigned an arbitrary score on an increasing 
506 scale. The total score is the sum of each response to the 8 items, of a possible score of 100. Computer scoring is 
507 not necessary.
508 Missing values. No instructions provided.
509 Score interpretation. Possible score range: 0–100, where 100 no symptoms or disability. Scores are categorized 
510 as excellent (95–100), good (84–94), fair (65–83), and poor (<64) (89).
511 Normative values. Normative data are available with and without stratification by sex (95,96).
512 Respondent burden. Time to complete has not been reported, but is expected to vary depending on the 
513 administration method (i.e., patient completed versus clinician administered). The Lysholm scale generally uses 
514 simple language in its questioning. However, it does use some specific medical terms such as locking, catching, 
515 and weight bearing. Administration of this scale as it was intended (i.e., clinician administered) would ensure 
516 adequate explanation of such terms, although this may vary between clinicians. As the items relate to everyday 
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518 Administrative burden. Less than 5 minutes to score. Training is not necessary, as the scale provides the 
519 corresponding score next to each possible response for each item.
520 Translations/adaptations. Since its original publication in English, several other translations have been accepted 
521 for use. An Arabic translation has been validated for OA, ligamentous, and meniscal injuries (97). Cross-cultural 
522 adaptations specifically for ACL injuries have been translated and validated in the Chinese and Dutch languages 
523 (98, 99) An Italian version demonstrates equivalence to the English version for assessing patellofemoral 
524 pathology (100). A German translation was found to be valid and reliable in assessing patients following total 
525 knee arthroplasty (101). Turkish and Spanish adaptations have also been accepted for use in assessing 
526 ligamentous pathology (102).
527
528 Psychometric Information
529 Method of development. Items pertaining to limp, support, stairs, squatting, and thigh atrophy were selected, 
530 and items for pain and swelling were adapted from the modified Larson scoring scale (103). The authors added 
531 the item for instability, as they deemed this to be an important component of the disability associated with ACL 
532 injury (88). The revised scale does not report how the item for locking was selected (89). Four groups of patients 
533 were used to compare the original scale to the modified Larson scoring scale: 1) knee ligament injury and 
534 anteromedial, anterolateral, and combined anteromedial/anterolateral instability; 2) knee ligament injury and 
535 posterolateral rotatory or straight posterior instability; 3) meniscus tears; and 4) chondromalacia patellae (88). 
536 Item-response theory was not used in the development of the Lysholm scale.
537 Acceptability. Rates of missing data have not been reported. There are consistent reports of no floor or ceiling 
538 effects (i.e., 15% of patients score the lowest or highest score, respectively) (75, 90, 104-107).
539 Reliability. The Lysholm scale appears to have inadequate internal consistency in patients with a variety of knee 
540 conditions (Table 1). Test–retest reliability is adequate for use in groups with knee injuries, but is less than 
541 adequate for groups with mixed knee pathologies. Reliability may be inadequate for use in individuals. The 
542 minimal detectable change has been reported as between 8.9 and 10.1 for knee injuries, while the standard 
543 error of the measure is reported to range from 3.2 to 3.6 for knee injuries and from 9.7 to 12.5 for mixed knee 
544 pathologies.
545 Validity. Face and content validity. The Lysholm scale has been reported as having face validity, as evaluated by 
546 5 orthopedic surgeons with sports medicine experience (75). Because the items in the Lysholm scale are surgeon 
547 derived, content validity from the patient’s perspective cannot be assumed.
548 Construct validity. Multiple studies have reported convergent construct validity for the Lysholm score, finding 
549 significant correlations with the Hospital for Special Surgery modified knee ligament rating system, Cincinnati 
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551 Fulkerson and Kujala scores, and Western Ontario and McMaster Universities Osteoarthritis Index (106-108). 
552 Two studies have reported evidence of convergent and divergent construct validity, finding the Lysholm score to 
553 correlate more highly with the Short Form 12 and Short Form 36 physical components than mental components 
554 (75, 90). The Lysholm score was shown to satisfy the Rasch model after removal of the item for swelling in 
555 patients awaiting surgery for knee chondral damage (92).
556 Ability to detect change. Large effect sizes have been reported following ACL reconstruction (6–9 months 
557 postoperative), meniscal repair (1 year postoperative), and microfracture (1–6 years postoperative) (Table 2). 
558 Large effect sizes are also reported following 1 month of physical therapy in a group of patients with mixed knee 
559 pathologies. 
560 Minimal Important Difference. The minimum clinically important difference (MCID) and patient-acceptable 
561 symptom state (PASS) have not been calculated in any patient population. Specifically, when comparing 
562 responsiveness following autologous chondrocyte implantation (ACI),The Lysholm and IKDC were the most 
563 sensitive to detecting changes when compared with MCKRS, KOOS, and SF-36 (109) .
564 Critical Appraisal of Overall Value to the Rheumatology Community
565 Strengths. The Lysholm scale is a freely available measure that is able to detect change following nonsurgical 
566 and surgical intervention. It is considered to have face validity by orthopedic surgeons. Because the Lysholm 
567 scale assesses everyday activities as opposed to higher functional activity, delayed return to sport has little 
568 impact on the LKS. Therefore, LKS may be ideal for assessing short term outcomes, or outcomes in patients not 
569 intending to return to a specific sport (109).
570 Caveats and cautions. Content validity cannot be assumed, as the items included in the Lysholm scale were 
571 surgeon derived. The Lysholm scale was developed as a clinician-administered tool, which increases the 
572 potential for interviewer bias if the patient-reported outcome is applied as intended. Despite this, there are 
573 inconsistencies between methods of administration of the Lysholm scale in published studies. The MCID and 
574 PASS are lacking in psychometric analysis.
575 Clinical usability.  Minimal administrative and respondent burden makes the Lysholm scale attractive for clinical 
576 use. The lack of floor and ceiling effects across different knee conditions suggests that the Lysholm scale is useful 
577 for tracking improvement with intervention as well as deterioration over time in patients with various knee 
578 pathologies. However, clinicians should consider the impact of inadequate reliability in evaluation of individuals.
579 Research usability. The Lysholm scale is reliable for use in research on ligamentous injuries of the knee, 
580 chondral injuries, and patellar dislocation. The use of Lysholm and IKDC together has proven to represent a 
581 responsive combination for efficiently evaluating treatment effects following autologous chondrocyte 
582 implantation (109).  It is important that researchers consistently utilize the same scale version (89). Researchers 
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584 ensure consistent administration within and between studies, and be aware that clinician and patient ratings 
585 may differ substantially. Lack of known MCID is a weakness.
586
587 TEGNER ACTIVITY SCORE (TAS) Description
588 Purpose. To provide a standardized method of grading work and sporting activities (89). Developed to 
589 complement the Lysholm scale, based on observations that limitations in function scores (Lysholm) may be 
590 masked by a decrease in activity level (89).
591 Intended populations/conditions. Intended for use in conjunction with the Lysholm Knee Scoring Scale, originally 
592 in patients with anterior cruciate ligament (ACL) injury (89).
593 Version. Although in some circumstances it has been modified slightly to accommodate different populations, 
594 the standard TAS remains in its original format.
595 Content. Graduated list of activities of daily living, recreation, and competitive sports. The patient selects the 
596 level of participation that best describes their current level of activity.
597 Number of items. One item is selected from a list of 11.
598 Response options/scale. A score of 10 is assigned based on the level of activity that the patient selects. A score 
599 of 0 represents “sick leave or disability pension because of knee problems,” whereas a score of 10 corresponds 
600 to participation in national and international elite competitive sports (89). Activity levels 6–10 can only be 
601 achieved if the person participates in recreational or competitive sport.
602 Recall period for items. Current ability.
603 Cost to use. Freely available in the original publication (89).
604
605 Practical Application
606 Method of administration. Originally established as an in-person, clinician-administered tool (110), but has been 
607 used more recently as a patient-completed questionnaire (90, 111).
608 Scoring. A score of 10 is assigned based on the level of activity that the patient selects as best representing their 
609 current activity level. Computer scoring is not necessary. Missing values. Not applicable (single score).
610 Score interpretation. Possible score range: 0–10. Higher scores represent participation in higher-level activities.
611 Normative values. Normative data have been presented by sex and age group (95).
612 Respondent burden. Reported to take mean  SD 3.3  0.6 minutes to complete in those who have undergone 
613 total knee replacement (112). The scale classifies work, recreational, and sport activities in a graded activity 
614 scale, using common terminology. As such, patients should not have difficulty selecting which level corresponds 
615 to their current activity. Degree of difficulty (measured on a visual analog scale) has been reported to increase 
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617 Administrative burden. Scoring time is negligible, as the score is based on a single selected item. Training is not 
618 necessary.
619 Translations/adaptations. Available in English. Cross-cultural translations are now validated for use in the 
620 Swedish, Dutch, German, Chinese, and Iranian populations for use in ACL injuries, and a German translation has 
621 been validated for use in the TKA population (99,101,113-115). Use in other rheumatology populations has 
622 consisted of ankle and shoulder disorders.
623 Psychometric Information
624 Method of development. Orthopedic surgeons selected items they believed to be difficult for patients with ACL 
625 injury. Forty-three patients with ACL-deficient knees then completed a questionnaire in which they graded these 
626 activities according to how difficult they were. This formed the basis of item selection for the TAS. Both paper 
627 and electronic forms have found to be reliable methods of administration (93).
628 Acceptability. Studies consistently report no floor or ceiling effects in those with knee injury or OA (i.e., 15% 
629 scored lowest or highest score, respectively)
630 (90, 101 , 104 , 112).
631 Reliability. The TAS has adequate test–retest reliability for groups with knee injuries and knee OA, although 
632 reliability is less than adequate for use in individuals (Table 1). For knee injuries, the minimal detectable change 
633 is 1, while the standard error of the measure ranges from 0.4–0.64.
634 Validity. Face and content validity. At face value, the TAS covers a wide variety of activity levels that may be 
635 applicable to patients with ACL and other knee injuries. However, as initial activity selection was conducted by 
636 orthopedic surgeons, with patient input afterward regarding the difficulty of these selected activities, content 
637 validity cannot necessarily be assumed.
638 Construct validity. Evidence for convergent and divergent construct validity is provided by studies that found 
639 higher correlations with the physical component of the Short Form 12 than the mental component (90, 101, 
640 112). The TAS has also shown significant correlations with the International Knee Documentation Committee 
641 Subjective
642 Knee Evaluation Form, Knee Society Score function score, Western Ontario and McMaster Universities 
643 Osteoarthritis Index pain and function subscales, and Oxford Knee Score (90, 101, 104, 112).
644 Generalizability. The Tegner Score was found to be reliable in both adult and pediatric populations (116).
645 Ability to detect change. Following meniscal surgery, moderate effect sizes are seen 12 months postoperatively 
646 in those with isolated meniscal lesions, and large effect sizes are seen in those with combined lesions (Table 2). 
647 In those who have undergone ACL reconstruction, effect sizes are reported to be moderate at 6 months and 
648 large at 9 months, 1 year, and 2 years. The minimum clinically important difference (MCID) and patient-
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650
651 Critical Appraisal of Overall Value to the Rheumatology Community
652 Strengths. The TAS is a simple freely available measure of activity level that spans work, sporting, and 
653 recreational activities. It is one of the few patient-reported outcomes that were developed to consider the 
654 influence of activity level on other symptoms, such as pain alleviation when aggravating activities are avoided. 
655 The Tegner score was found to have clear benefits over other PROMs, and is the preferred PROM for ACL 
656 injuries in the UK (117) .
657 Caveats and cautions. The TAS was originally intended and developed for patients with ACL injury as an adjunct 
658 to the Lysholm scale, not as a stand-alone measure. The MCID is missing from psychometric analysis. Studies 
659 suggest that TAS data need to be adjusted for age and sex
660 (118).
661 Clinical usability. Clinicians should note that its reliability may be inadequate for use in individuals.
662 Research usability. Although valid and reliable for use in groups, use of the TAS in research may need to be 
663 applied with caution. Given its intent to measure change within patients, the TAS may be more appropriate for 
664 within-subject repeated measures studies rather than between-group comparisons.
665
666
667 OXFORD KNEE SCORE (OKS) 
668 Description
669 Purpose. Brief questionnaire for patients undergoing total knee replacement (TKR) that reflected the patient’s 
670 assessment of their knee-related health status and benefits of treatment (119).
671 Intended populations/conditions. Patients undergoing TKR.
672 Version. A new version was proposed on the basis that some surgeons believed that the scoring of the original 
673 version was non-intuitive (i.e., lower scores represented better outcome, higher scores represented worse 
674 outcome), where the original 12 items are used but the scoring is different (120).
675 Content or domains. Single index pertaining to knee pain and function (pain severity, mobility, limping, stairs, 
676 standing after sitting, kneeling, giving way, sleep, personal hygiene, housework, shopping, and transport). The 
677 questionnaire can be separated into pain and function subscales with good validity and responsiveness (121).
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679 Response options/scale. Each item is followed by 5 responses (scores ranging from 1–5), where 1 is the best and 
680 5 is the worst outcome. The modified version also has 5 responses to each item, but the scoring is from 0–4, 
681 where 0 is the worst and 4 is the best outcome.
682 Recall period for items. Previous 4 weeks.
683 Cost to use. Free.
684 How to obtain. The original version can be found in its original publication (119). The modified version is freely 
685 available online (http://www.orthopaedicscore.com/scorepages/oxford_knee_score.html) (120).
686
687 Practical Application
688 Method of administration. Patient-completed questionnaire.
689 Scoring. Originally, each response to each item was assigned a score from 1–5 (where 1  no problem and 5  
690 significant disability). The modified version assigns a score from 0–4 (where 4  no problem and 0  significant 
691 disability). The total score is calculated as the sum of scores from responses to all 12 items.
692 Missing values. No instructions provided.
693 Score interpretation. In the original version, the total score ranges from 12–60 (119), while in the modified 
694 version the total score ranges from 0–48 (120). Higher scores in the original version reflect poor outcome and 
695 lower scores reflect better outcomes. In the modified version, this is reversed.
696 Normative values. Not available.
697 Respondent time to complete. Reported to involve minimal respondent burden (119). It takes approximately 5–
698 10 minutes to complete the questionnaire. No training or assistance is required since the questions are self-
699 explanatory. 
700 Administrative burden. Scoring is simple and quick (119). Calculation of the total score takes 1–5 minutes. No 
701 training is necessary.
702 Translations/adaptations. Translated and validated in many languages, including Arabic (122, 123), Chinese 
703 (124-126), Finnish (127), German (128), Japanese (129), Korean (130), Persian (131, 132), Portugese (133), 
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706 Psychometric Information
707 Floor and ceiling effects. A study reported no floor or ceiling effects prior to TKR (74). Six months 
708 postoperatively, although there were no floor effects, there were ceiling effects reported (27% of patients 
709 scored the top score). Conversely, one study found large floor effects at an average of 18 months post-
710 operatively, with no ceiling effect (138). Furthermore, the ceiling effect has been shown to increase from 6 
711 months to 2 years post operatively from TKR, while no floor effect was found at either time point (139). Another 
712 study found no floor or ceiling effects in patients with knee OA (134).
713 Reliability. The OKS has adequate internal consistency across multiple languages (119, 124, 128, 129, 135, 136) 
714 (Table 1). The original study reported adequate test–retest reliability for use in groups and individuals (119). 
715 There test-retest reliability was confirmed in patients with OA being managed non operatively (140).
716 Validity. Face and content validity. Extensive input from patients in the development of the OKS ensures content 
717 validity.
718 Construct validity. The OKS shows good correlation with knee-specific and general health questionnaires, such as 
719 the Western Ontario and McMaster Universities Osteoarthritis Index, American Knee Society Score, Knee 
720 Outcome Survey Activities of Daily Living Scale, and pain and physical function components of the Short Form 36 
721 and Health Assessment Questionnaire (119, 141). Internal and external validity is adequate post-operatively 
722 (138). Convergent and divergent construct validity is demonstrated by higher correlations with the Short Form 
723 12 physical than mental component (74). Convergent and divergent validity has also been confirmed when the 
724 pain and function subscales of the OKS has been separately compared to other outcome scores (140). The OKS 
725 has been shown to fit Rasch models following rescoring of some items (142), and removal of items for limp and 
726 kneeling (143).
727 Responsiveness. The OKS demonstrates good sensitivity and responsiveness to change (Table 2). 
728 Responsiveness is consistent whether using raw OKS data or after Rasch analysis (139). Large effect sizes have 
729 been reported 6–12 months after TKR (119, 144) and 1 year after high tibial osteotomy (145). The OKS has also 
730 been found to be a good predictor of revision TKR within 6 months (146), and is also a predictor of range of 
731 motion after TKR (147). The effect size is larger in patients who report positive changes in their knee symptoms 
732 over time compared to patients who report a negative progression in symptoms (134). 
733 Minimally important differences. The minimum detectable change (MDC95) after high tibial osteotomy was 
734 reported to be 8.29 (145). The minimum detectable change (MDC90) and minimal important change (MIC) 6 
735 months after TKR were found to be 4.15 and 9.22, respectively (148). In patients with knee OA, the MDC90 after 
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737 same patient cohort, the MIC for the total OKS was 7.1, the MIC for OKS the pain subscale was 17.3, and the MIC 
738 for the function subscale was 10.6. Patient acceptable symptom state has not been reported.
739 Generalizability. The OKS was intended for use in patients with knee OA before and after TKR. It is likely 
740 generalizable to many knee conditions and many different populations due to the consistent reliability, validity, 
741 and responsiveness that is found in the literature.
742 Use in clinical trials. None reported.
743 Other: Patients are able to recall their pre-operative health status in regards to the OKS with good consistency 
744 (149), even up to 1 year post-operatively (150). 
745 Critical Appraisal of Overall Value to the Rheumatology Community
746 Strengths. The OKS is a self-administered questionnaire developed to measure outcome following TKR. Due to 
747 simplicity and ease of administering, it has been used widely, especially in the UK, and is available in languages 
748 other than English. For the same reasons, it can be used as a cost-effective screening tool in short-term (2 years) 
749 followup of TKR compared to physician administered instruments, such as the American Knee Society Score, as 
750 reported by 1 study (151). It may be separated into pain and function subscales.
751 Caveats and cautions. Although simple, some items are “double barreled” and may be confusing to patients 
752 (e.g., trouble getting in and out of a car or using public transportation). Some response options potentially 
753 overlap with others, which may also cause confusion. The use of an aggregate score combining pain and 
754 function may mask changes in 1 domain, particularly given that only 1 of the 12 items relates solely to pain. If 
755 separated into pain and function subscales, must be aware of the complex interaction between pain and 
756 function and therefore patient interpretation of the questions. The floor and ceiling effects post-operatively 
757 make post-operative comparisons and distinctions more difficult.
758 Clinical usability. Psychometric testing suggests that the OKS is sufficiently reliable for use in individuals with 
759 knee OA. The ease of administration and scoring makes it a useful tool for clinical use. However, clinicians 
760 should be aware that some patients may require explanation of individual items, which could introduce 
761 interviewer bias.
762 Research usability. The OKS is a knee OA–specific measure that is reliable, valid, and responsive to change 
763 following TKR. Researchers should be aware of the different scoring methods when interpreting findings of 
764 previous research. It is correlated with the American Knee Society Score, and therefore these scores can be 
765 directly compared (152). 
766
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768 Description
769 Purpose. To assess the course of disease or response to treatment in patients with knee or hip osteoarthritis 
770 (OA) (153, 154).
771 Intended populations/conditions. Patients with knee and hip OA (153,154).
772 Version. Initially developed in 1982, the WOMAC has undergone multiple revisions (most recent version 3.1). It 
773 is available in 5-point Likert, 100-mm visual analog scale (VAS), and 11-box numerical rating scales (155, 156). 
774 Reduced and modified versions of the WOMAC have been validated but are not endorsed on the WOMAC web 
775 site (157-159, 160).
776 Content or domains. Three subscales: 1) pain severity during various positions or movements, 2) severity of 
777 joint stiffness, and 3) difficulty performing daily functional activities.
778 Number of items. 24 items.
779 Response options/scale. In the Likert version, each item offers 5 responses: “none” scored as 0, “mild” as 1, 
780 “moderate” as 2, “severe” as 3, and “extreme” as 4. Alternatively, the VAS and numerical rating scale versions 
781 permit responses to be selected on a 100-mm or 11-box horizontal scale, respectively, with the left end marked 
782 as “none” and the right end marked as “extreme” (153,154 ).
783 Recall period for items. 48 hours.
784 Cost to use. Not free, cost depends on research project.
785 How to obtain. Available from Professor Nicholas Bellamy (Australia, e-mail: n.bellamy@uq.edu.au). To obtain 
786 licensing and fee information and permission to use the WOMAC for clinical or research purposes a request 
787 needs to be submitted to http://www.womac.com.
788
789 Practical Application
790 Method of administration. Self-administered or interview-administered questionnaire. It has been validated for 
791 use in person, over the telephone, or electronically via a computer or mobile phone (154, 161-164). Electronic 
792 and paper questionnaires show high agreement (165).
793 Scoring. The total score for each subscale is the sum of scores for each response to each item, and can be 
794 calculated manually or using a computer. The range for possible subscale scores in the Likert format are: pain 
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796 format, the ranges for the 3 subscale scores are: pain, 0–500; stiffness, 0–200; and physical function, 0–1,700 
797 (153,154).
798 Missing values. If 2 or more pain items, both stiffness items, and 4 or more physical function items are missing, 
799 the response should be regarded as invalid and the deficient subscale(s) should not be used in analysis (153).
800 Score interpretation. Higher scores indicate worse pain, stiffness, or physical function.
801 Normative values. Australian population-based normative data have been reported, stratified by age and sex 
802 (166). 
803 Respondent time to complete. 5–10 minutes to complete.
804 Administrative burden. Approximately 5 minutes to score. Training is not necessary.
805 Translations/adaptations. WOMAC version 3.1 is available in over 100 languages (155), and has validated 
806 language translations for Arabic (167), Arabic reduced (168), Bangladesh (169), Chinese (170, Symonds 2015 
807 171), Finnish (172), German (173), Greek (174), Hebrew (175), Italian (176), Japanese (177), Korean (178), 
808 Moroccan (179), Nepali (180) Persian (131), Portuguese-Brazil (181) Singapore (182), Spanish (183), Swedish 
809 (184, 185), Thai (186), and Turkish (187,188).
810 Psychometric Information
811 Floor and ceiling effects. Reports of floor and ceiling effects have differed between studies (74, 170, 186, 188, 
812 189). The stiffness subscale has been reported as having floor and ceiling effects prior to intervention (74, 170, 
813 188), as well as up to 1 year postoperatively from TKR (190). Ceiling effects have been reported by various 
814 studies for all subscales 6 months and 2 years after TKR (74, 189).
815 Reliability. The stiffness and function subscales have consistently demonstrated adequate internal consistency 
816 in knee OA (Table 1). Studies have generally reported adequate internal consistency for the pain subscale, 
817 although there have been reports slightly lower than adequate. There have been mixed findings regarding 
818 adequacy of test–retest reliability in knee OA for all subscales. Test– retest reliability for the stiffness subscale 
819 may not be adequate for use in individuals with knee OA. One study that investigated test–retest reliability in 
820 patients with chondral defects found that all subscales had adequate reliability for use in groups, but only the 
821 function subscale was adequate for individual use. However, the “putting on socks” item of the physical function 
822 subscale may present problems in stability and variance when analyzed with the Rasch model (191). 
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824 193) The minimal detectable change and standard error of the measure vary according to condition and 
825 subscale. These measures tend to increase over time, and the reliability decreases over time (87).
826 Validity. Face and content validity. Since the WOMAC was developed with extensive input from patients with 
827 OA, as well as input from academic rheumatologists and epidemiologists experienced in clinical assessment of 
828 rheumatologic diseases, the WOMAC can be considered to have face and content validity. 
829 Construct validity. Multiple studies have shown that the WOMAC subscales demonstrate good construct validity. 
830 Moderate to strong correlations with measures of similar constructs (e.g., Short Form 36 [SF-36] physical 
831 subscales, pain/handicap VAS) suggest convergent construct validity (170, 175, 176, 179, 187, 188, 194, 195), 
832 while lower correlations with measures such as the SF-36 mental subscales indicate divergent construct validity 
833 (170, 176, 187, 188, 195). Convergent validity was also demonstrated with strong correlation with the 30 second 
834 chair stand and 50 foot timed walk tests (196). Although Rasch analyses have largely utilized mixed knee and hip 
835 OA cohorts, it has been reported that there is no differential item functioning based on affected joint (197). 
836 While 1 study found the pain subscale to demonstrate good item separation and unidimensionality in patients 
837 with knee or hip OA (198), a subsequent study found that a reduced pain subscale (night pain and pain on 
838 standing removed) fit the Rasch model and provided more stable results over time and between patients with 
839 knee or hip OA and those who have undergone joint replacement (197). The function subscale demonstrates 
840 more variability. Although found to have good item separation and unidimensionality in knee/ hip OA, function 
841 items for performing light chores, getting in/out of a car, and rising from bed were found to be redundant (198). 
842 Similarly, Davis et al (197) suggested a 14-item function subscale, with items for heavy domestic duties, getting 
843 in/out of the bath, and getting on/off the toilet removed. There is a strong correlation with psychological 
844 measures and total WOMAC score, indicating poor divergent validity (199). Hip abductor and knee extensor 
845 strength are not correlated with WOMAC function subscale (200)
846 Responsiveness. The WOMAC appears to be responsive to change following surgical and nonsurgical 
847 interventions for knee OA and chondral defects (Table 2, 201). A recent study has confirmed the high 
848 responsiveness in patients undergoing TKR with a mean change in score of 29 at 3 months post operatively 
849 (202). In particular, the physical function domain has been suggested to be the best choice for detecting changes 
850 over time compared to other measures (203). However, in patients undergoing exercise therapy, the total 
851 WOMAC was found to be more responsive than the physical function subscale (204). In patients with knee OA, 
852 large effect sizes are consistently reported on all 3 subscales up to 2 years post-TKR. This was recently confirmed 
853 at one 1 year postoperatively, however the stiffness subscale has a smaller effect size than pain or function 
854 (205). Furthermore, effect size decreases over time up to 2 year after TKR (190). Following exercise intervention, 
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856 and function subscales; however, these also are small at 6 months. Acupuncture has shown small to moderate 
857 effect sizes in the short term (3 weeks), but large effect sizes after 8 weeks. Drug intervention tends to show 
858 different patterns across 12 weeks for the 3 subscales. Effect sizes for pain tend to be large initially (1 week), and 
859 become more variable at 6 weeks (moderate to large) and 3 months (small to large). In comparison, the stiffness 
860 subscale tends to show small to moderate effect sizes over the initial 4 weeks, becoming moderate to large by 3 
861 months. Similarly, effect sizes for function also gradually increase, starting at moderate at 2 weeks, and 
862 becoming moderate to large at 6 and 12 weeks. Following surgery for chondral defects, large effect sizes are 
863 seen for pain and function 6 and 12 months postoperatively, while moderate effect sizes are seen on the 
864 stiffness subscale. Using composite WOMAC outcomes by combining the subscales improves responsiveness and 
865 reduces the necessary sample size (206). The reduced WOMAC has been shown to have similar responsiveness 
866 to the original WOMAC (207). 
867 Minimally important differences. The minimum clinically important difference has been calculated for TKR (up 
868 to 2 years postoperatively; range for pain 22.9–36, range for symptoms 14.4–21.4, range for function 19–33) 
869 and nonsteroidal antiinflammatory use (4 weeks; function 9.1). At 3 months post operatively, the MCID was 
870 determined to be 10.21 (202). The patient-acceptable symptom state has been determined to be 31.0 (95% 
871 confidence interval 29.4–32.9) for the function subscale in people with knee OA (208). The minimum important 
872 change has also been determined for the short WOMAC, 7.9 and 9.8 points for small change, 8.4 and 9.8 points 
873 for medium change, and 12.1 and 10.1 points for large change (209).
874 Generalizability. The WOMAC has been mainly used for OA and TKR, however it has been used in other knee 
875 pathologies. Due to the consistent reliability, validity, and responsiveness that is found in the literature it can be 
876 inferred that it is generalizable to many knee conditions and many different populations.
877 Use in clinical trials. The WOMAC was used to assess efficacy of the addition of oxygen therapy to usual therapy 
878 in patients experiencing a flare of knee arthritis (210). The effect of patellofemoral overstuffing on clinical 
879 outcomes was also investigated with the WOMAC as the primary outcome (211). The WOMAC was a primary 
880 outcome measure in a trial investigating tanezumab for hip and knee arthritis (212). It has also been used as the 
881 primary outcome measure in a trial assessing the impact of change in physical activity on pain and physical 
882 function (213). A trial of aqueous extract of Terminalia chebula fruit as a dietary supplement in overweight, 
883 healthy adults used the modified WOMAC as a primary outcome (214). Pain progression evaluated using the 
884 WOMAC was associated with radiographic and MRI evaluation of cartilage loss in symptomatic knee 
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886 Critical Appraisal of Overall Value to the Rheumatology Community
887 Strengths. The WOMAC is one of the most commonly used patient-reported outcomes for knee OA. It is simple 
888 and quick to administer and score using guidelines provided. The utilization of patients in development ensures 
889 content validity. In addition, the WOMAC has undergone validated translations into multiple languages. The use 
890 of individual scores for each subscale, rather than an aggregate score, enhances interpretation.
891 Caveats and cautions. The need to obtain permission and pay licensing fees prior to use may encourage 
892 researchers and clinicians to seek alternatives. The inclusion of tasks in the function subscale that may not be 
893 performed regularly by all patients (e.g., stair climbing, taking a bath) may result in missing data. Content validity 
894 is not ensured for more physically active patients since the function scale does not include more difficult 
895 functional tasks. Rasch analysis suggests that the function subscale contains redundant items. The physical 
896 function domain has a stronger association with pain compared to performance. Patients have to recall 
897 symptoms during specific movements. There is a correlation between patient psychological status and WOMAC 
898 score. Reliability and responsiveness decrease with time.
899 Clinical usability. The variability in administration methods makes the WOMAC a good choice for clinical use, 
900 particularly when dealing with patients with communication difficulties. Minimal floor effects means that the 
901 pain and function subscales are able to monitor deterioration in condition over time, while ceiling effects have 
902 only been reported following TKR. However, clinicians should consider that the stiffness subscale may not be 
903 sufficiently reliable for use in individuals. An additional physical function measure may be employed to ensure 
904 that this construct is fully measured due to its association with pain.
905 Research usability. Psychometric testing indicates that the WOMAC is sufficiently reliable and valid for use in 
906 research. The variety of validated language translations and methods of administration is a major strength for 
907 WOMAC use in research. A body of research supports the responsiveness to change of the WOMAC following 
908 surgical and nonsurgical interventions. Extensive use of the WOMAC in previous research facilitates comparison 
909 of new findings.
910 ACTIVITY RATING SCALE (ARS) Descriptive
911 Purpose. Developed as a short, simple, knee-specific questionnaire to evaluate the activity level of patients with 
912 various knee disorders who participate in different sports. Intended to provide data on an athlete’s highest 
913 activity level within the past year (i.e., at a time when they were most active) (216).
914 Intended populations/conditions. Various knee conditions, including ligament, meniscus, and chondral injury; 
915 patellofemoral pain; osteochondritis dissecans; trabecular fracture; and iliotibial band syndrome (216).
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917 Content. Single index pertaining to frequency of athletic activities: 1) running, 2) cutting, 3) decelerating, and 4) 
918 pivoting.
919 Number of items. 4 items.
920 Response options/scale. Each item is followed by 5 responses for the frequency of each functional component 
921 within the past year.
922 Recall period for items. 1 year.
923 Endorsements. None.
924 Examples of use. Conditions: anterior cruciate ligament (ACL) injury, cartilage injury, and knee osteoarthritis. 
925 Interventions: ACL reconstruction, autologous chondrocyte implantation, microfracture, high tibial osteotomy, 
926 and total knee replacement.
927 Practical Application
928 How to obtain. The ARS can be found as an appendix in the original publication (216).
929 Method of administration. Patient-completed questionnaire, either paper or electronically administered, with 
930 particularly high rates of agreement for the Activity Rating Scale (ARS) (217). ARS not yet been validated for 
931 interview administration (telephone, in person).
932 Scoring. Each item is scored from 0–4, where 0  “less than 1 time a month,” 1  “one time in a month,” 2  “one 
933 time in a week,” 3  “two to three times in a week,” and 4  “four or more times in a week.” The total score is the 
934 sum of scores from responses to each of the 4 items (216). Missing values. No specific instructions for handling 
935 missing values.
936 Score interpretation. The total possible score range is 0–16, where 16 represents more frequent participation.
937 Normative values. Not available.
938 Respondent burden. Approximately 1 minute to complete. Respondent burden was intentionally minimized 
939 through the inclusion of only 4 items (216).
940 Administrative burden. Less than 5 minutes to score. No training is required.
941 Translations/adaptations. A Cross-cultural adaptation has been conducted for the Swedish translation (218), 
942 and a Persian version has been translated and validated specifically for ACL injuries (219). 
943 Psychometric Information
944 Method of development. Items were selected by literature review, expert opinion (orthopedic surgeons who 
945 specialized in sports medicine, physical therapists, and athletic trainers), and surveying patients with knee 
946 disorders. Item reduction involved 50 patients with a variety of knee disorders who were physically active who 
947 rated the importance and difficulty associated with each functional task on the preliminary list. The top 4, as 
948 agreed by the panel of clinicians, were retained in the final version (216).
















This article is protected by copyright. All rights reserved
950 Reliability. One study has evaluated the test–retest reliability of the ARS, finding adequate reliability for use in 
951 groups and individuals (216) (Table 1). The internal consistency has not been reported.
952 Validity. Face and content validity. The use of patients with knee disorders in both item selection and reduction 
953 ensures content validity. Final item selection also involved the opinion of clinicians to ensure face validity
954 (216).
955 Construct validity. The ARS has been reported to have moderate to strong correlation with other knee-related 
956 scales that measure activity levels, such as the Tegner Activity Score, Cincinnati Knee Ligament Score, and Daniel 
957 Score, suggesting good convergent construct validity (216).
958 Generalizability. Previously, the ARS had only been validated for adult use. However, a study published in 2015 
959 found ARS to be reliable in patients younger than the age of 18 in knee injuries, with decreasing reliability in 
960 patients younger than 14. Test-retest data confirmed its reliability in all but 1 of the questions in the age >14<18 
961 cohort. While the questionnaire may prove useful in this pediatric population, its usefulness may be limited by 
962 the significant ceiling effect observed, as more than half of the patients had maximum scores of 16 (50.6%) 
963 (220).
964 Ability to detect change. The responsiveness, minimum clinically important difference, and patient-acceptable 
965 symptom state have not been reported (Table 2). Rasch analysis was not performed.
966 Critical Appraisal of Overall Value to the Rheumatology Community
967 Strengths. The ARS is a short simple measure that represents minimal administrator or respondent burden. As it 
968 assesses 4 common components of various sporting activities, rather than nominating specific sports, it is 
969 generalizable across a wide range of elite and recreational athletes. In addition, to the extent that activities such 
970 as running, stopping, and changing direction are also needed for nonsport activities, it could be applicable to 
971 other situations (e.g., work tasks).
972 Caveats and cautions. Since its focus is limited to specific activities, it is important to assess activity related 
973 scales, in conjunction with questionnaires used to evaluate pain and function, as activity level may be 
974 particularly important as a potential confounding variable when evaluating patient outcomes following knee 
975 injuries. Often, an inverse relationship is observed when administered together. Some patients may report pain 
976 and functional limitations, but are able to return to a higher level of activity. Or perhaps, the higher level of 
977 activity is associated with increased pain and perceived limitations. Inversely, patients may report better 
978 outcomes in pain and function, but report lower ARS scores as a result of lifestyle changes made to avoid 
979 symptoms and risk of re-injury (221). Therefore, the utility of an activity rating scale is maximized as an adjunct 
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982 Other activities such as swimming and jumping cannot be evaluated by this scale. Furthermore, since the ARS 
983 does not focus on current ability, but on baseline activity frequency perhaps prior to injury, the validity of the 
984 instrument depends on the subject’s accurate recollection of this frequency. The accuracy of such recollection 
985 may be influenced by the time since injury and by the current state of activity. Lack of evidence for 
986 responsiveness to change/sensitivity is also a limitation. The ARS should be used as an adjunct to other knee 
987 instruments assessing symptoms and difficulty (216).
988 Clinical usability. The ARS is a short activity-specific questionnaire, making it good for clinical use. It would be 
989 suitable for patients who participate in land-based sports or activities that do not involve jumping as a primary 
990 movement. Clinicians should consider that the 1-year recall period may be difficult for some patients.
991 Research usability. The lack of psychometric data for the ARS limits its use in research. As the scale measures 
992 the highest level of activity over the past year, without taking into account time of injury, it may be more suited 
993 for within-subject study designs, rather than comparing ratings between subjects.
994
995 PATIENT REPORTED OUTCOME MEASUREMENT INFORMATION SYSTEMS- PHYSICAL FUNCTION (PROMIS-PF)
996 Description
997 Purpose. To measure self-reported capability rather than actual performance of physical activities. This includes 
998 the functioning of one’s upper extremities (dexterity), lower extremities (walking or mobility), and central 
999 regions (neck, back), as well as instrumental activities of daily living, such as running errands (223).
1000 Content. The Patient-Reported Outcome Measurement Information Systems (PROMIS), funded by the NIH, was 
1001 developed to be a tool for both clinicians and researchers to access efficient, precise, valid and responsive adult 
1002 and pediatric PROMs in health and well-being. (224). This tool is unique as it is useful in various disciplines in 
1003 measuring physical, mental, and social health in individuals with chronic conditions (223). There are multiple 
1004 subscales specific to the goals of measurement and patient population. The physical function form of PROMIS 
1005 specifically measures the ability to carry out various activities that require capability, ranging from self-care to 
1006 more vigorous activities of mobility, strength and endurance (223).
1007 Number of items. Form 10a has 10 items. The first 5 focus on the degree to which the patient’s health limits 
1008 their activities: vigorous, walking, climbing stairs, carrying groceries, bending or kneeling. The second 5 focus on 
1009 difficulty in carrying out ADLs: vacuuming or yard work, dressing, shampoo hair, wash and dry body, and use the 
1010 toilet. 
1011 Recall period for items. There is no specification of recall period
1012 Cost to use. The PROMIS forms are free to use in the single use forms. Integrated data collection and 
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1018 Method of Administration. PDF forms are available as well as integrated data collection tools through 
1019 HealthMeasures (http://www.healthmeasures.net/resource-center/data-collection-tools). 
1020 Scoring. Scoring. Creators of the PROMIS intended the measurement to be scores according to response pattern 
1021 scoring with item-level calibrations using the Health Measures Scoring Service 
1022 (33TU33TUhttps://www.assessmentcenter.net/ac_scoringservice). However, there is also a table to be used. 
1023 Each question has five response options, Likert, ranging 1-5. A score of 5 is equivalent to no limitation or 
1024 difficulty and a score of 1 is equivalent to being unable to complete. 
1025 Scoring Interpretation. The raw score ranges 10-50 and the scaled score ranges from 13.5 to 61.9. With 50 or 
1026 61.9 representing optimal physical function. The T-score rescales the raw score into a standardized score with a 
1027 mean of 50 and a standard deviation (SD) of 10. Therefore, a person with a T-score of 40 is one SD below the 
1028 mean. 
1029 Respondent time to complete. 5 Minutes
1030 Administrative Burden. Multiple integrative data options for all the PROMIS measures exist that would alleviate 
1031 any significant administrative burden, but come with variable price points. However, it takes about 3-5 minutes 
1032 to score manually on the single use PDFs. 
1033 Translations and adaptations. PROMIS physical function 10a is available in the following languages: English, 
1034 Spanish, Danish, Dutch, French, German, Hungarian, Italian, Polish, Russian, Simplified Chinese (Mandarin), 
1035 Traditional Chinese, and Ukranian.
1036
1037 Psychometric Information
1038 Floor and ceiling effects. Studies have shown no floor or ceiling effects with meniscal injuries, patellofemoral 
1039 malalignment, multi-ligamentous injuries, and chondral disease (225, 226, 228). In a study of 204 patients, 
1040 PROMIS-PF was found to have no floor effect, while one patient scored the highest possible score (227). When 
1041 compared to the KOOS-ADL, KOOS- sport and SF-36 PF, the PROMIS-PF had the lowest ceiling effect of the 
1042 instruments with 1.4% at 6 months and 9.0% at 2 years in patients with ACL injuries, well below the 15% cutoff 
1043 (229). 
1044 Reliability. Few studies have demonstrated reliability in the PROMIS-PF form. One study showed high reliability 
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1046 extremity physical function computer adaptive test based on PROMIS PF items found the items to demonstrate 
1047 high reliability (231).
1048 Validity. Hung and colleagues, when attempting to validate the lower extremity physical function computer 
1049 adaptive test based on PROMIS PF items, found the item bank to be unidimensional and free of item bias with 
1050 high content and construct validity (231). Another study by the same group showed adequate face validity as 
1051 well as construct validity (232). Good construct validity of the PROMIS-PF form in patients with rheumatoid 
1052 arthritis has also been shown (230, 233). Content validity was further shown in patients with patients with 
1053 Tenosynovial Giant Cell Tumors of the knee (234). Strong validity of comparisons for the PROMIS-PF items was 
1054 shown in patients with different musculoskeletal disorders namely chronic pain, rheumatoid arthritis and 
1055 osteoarthritis and there is high correlation with SF-36 scores (227, 235). Good convergence has been found 
1056 between the PROMIS-PF, KOOS and IKDC scales (236).
1057 Responsiveness. The PROMIS assessments collectively have been shown to be very responsive to change (237). 
1058 When compared to the KOOS-ADL, KOOS- sport and SF-36 PF, the PROMIS-PF showed equal responsiveness and 
1059 excellent utility in the postoperative ACL course (229). The PROMIS-PF was specifically found to have high 
1060 responsiveness to patients with OA, while pain, depression and anxiety PROMIS forms only have moderate 
1061 responsiveness (238). It has also been shown to compare well with disease specific scales in regards to knee 
1062 arthroscopy patients (236).
1063 Critical Appraisal of Overall Value to the Rheumatology Community
1064 Strengths. The PROMIS-PF can be used not only for a variety of conditions in the knee, but also a variety of 
1065 musculoskeletal and rheumatologically conditions. Further, with regards to the knee, it is comparable in 
1066 psychometric properties to disease-specific scales. There is low burden to the patient as well as low 
1067 administrative burden. There are also a lot of resources available to integrate scoring and maintaining data.
1068 Caveats and cautions. PROMIS has multiple subscales and forms that can be used. It is important to use the best 
1069 subscale for a given need. Psychometric properties have not been assessed for all knee conditions and the 
1070 PROMIS-PF score was not developed specifically to knee conditions.
1071 Clinical Usability. The PROMIS-PF is easy to use and has low respondent burden and administrative burden. It 
1072 can be used for many conditions.
1073 Research Usability. Easy to use in the research setting and has been shown to be comparable to other scales 
1074 that are specific to knee conditions. May allow for comparing similarities in physical function changes between 
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1077 SUMMARY / RECOMMENDATIONS
1078 We reviewed nine of instruments that have been developed to measure patient reported knee function and one 
1079 measure that has been used for overall physical function, but has been adequately tested for assessment of 
1080 knee related conditions. Since the last review of some of these knee measures was published in 2011, there has 
1081 been an enormous body of research evaluating their psychometric properties in patients with varying knee 
1082 conditions. Further, many tools have also been cross-culturally translated into multiple languages and adapted 
1083 where needed. While other measures may be useful (e.g., 239), this extensive review provides researchers with 
1084 the necessary information for the nine most commonly used instruments in trials in the last 10 years as well as 
1085 information for the PROMIS Physical Function. When seeking to use knee measures it might be useful to refer to 
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effects for 
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to change for OA. 
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OA focused and 
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content and face 
validity since 
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The TAS has 
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retest reliability for 
groups with knee 
injuries and knee 
OA, although 
reliability is less 
than adequate for 
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for use in groups  
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reported. 
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to change; large 
ES post-op; 
predicts revision 
TKR and range of 
motion after TKR 
MDC90 and 
MIC after 
TKR: 4.15 and 
9.22; non-op 
knee OA MIC: 
total 7.1, pain 
17.3, function 
10.6 
Useful in OA 
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of treatment, but 
may decrease 
over time 
MCID after PT 
for knee OA: 
2.2 at 2 mo, 5 
at 12mo 
Useful for a 
variety of knee 
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post-op, smaller 
ES for non-op 
management 
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Few studies have 
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reliability although 
one showed high 
reliability in RA 
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not specific to 
the knee and 
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psychometric 
analysis is 
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